OPSB

OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Mercoledì, Marzo 6, 2024
Acquisition, Deformity, International, Total, Infection, Investment, Marketing, Growth, Fixation (psychology), Response, Elective surgery, Orthopediatrics, Event, OPSB, Scoliosis, Webcast, Sport, Depreciation, Video game

Total revenue for the fourth quarter of 2023 was $37.6 million, a 21% increase compared to $31.0 million for the same period last year.

Key Points: 
  • Total revenue for the fourth quarter of 2023 was $37.6 million, a 21% increase compared to $31.0 million for the same period last year.
  • The increase in revenue in the fourth quarter of 2023 was driven primarily by growth across Trauma and Deformity, Scoliosis, and OPSB.
  • In the fourth quarter of 2023, we realized an immaterial fair value adjustment benefit compared to a $0.5 million benefit for the fourth quarter of 2022.
  • Adjusted EBITDA for the fourth quarter of 2023 was $1.3 million as compared to a loss of $2.2 million for the fourth quarter of 2022.

OrthoPediatrics Corp. Announces Launch of Specialty Bracing Division

Retrieved on: 
Mercoledì, Dicembre 6, 2023
Hip, Partnership, Levity, Brace, Immobilization, Knee, Acquisition, Trauma, Surgeon, Injury, Clubfoot, Femur, MDO, Elective surgery, Growth, Patient, AFO, OPSB, Dentistry

WARSAW, Ind., Dec. 06, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the launch of a new division, focused on non-surgical intervention for pediatric orthopedics.

Key Points: 
  • WARSAW, Ind., Dec. 06, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the launch of a new division, focused on non-surgical intervention for pediatric orthopedics.
  • The OrthoPediatrics Specialty Bracing division (“OPSB”) will serve as a flagship house of brands and innovative products that expand the Company’s Total Addressable Market by approximately $600 million.
  • Since the transaction, the Company has been aggressively building a portfolio of complementary products to address the large unmet needs for specialty bracing within the pediatric orthopedic market.
  • OrthoPediatrics’ President of Trauma & Deformity Correction, Joe Hauser will also lead the new non-operative business, commenting, “We are excited for the launch of the new OPSB division, and our continued expansion into pediatric orthopedic non-surgical treatments for kids.

OrthoPediatrics Corp. to Host Educational and Networking Events at 19th Annual International Pediatric Orthopaedic Symposium (IPOS)

Retrieved on: 
Lunedì, Dicembre 4, 2023
Emerald, Partnership, Surgeon, SCFE, Education, IPOS, Elective surgery, Orthopediatrics, OPSB

WARSAW, Ind., Dec. 04, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced plans to host educational and networking events at IPOS and its increased support of the event as an Emerald-Level sponsor.

Key Points: 
  • WARSAW, Ind., Dec. 04, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced plans to host educational and networking events at IPOS and its increased support of the event as an Emerald-Level sponsor.
  • IPOS, a branch of the Pediatric Orthopedic Society of North America (POSNA), is a leading educational meeting for pediatric orthopedic surgeons.
  • Over 500 pediatric orthopedic surgeons are registered to attend the meeting from December 5-9, in Orlando, Florida.
  • OrthoPediatrics IPOS 2023 Events include:
    Treatment Choices for SCFE – What to Choose and When?

OrthoPediatrics Corp. Launches MP+ Bar for Clubfoot

Retrieved on: 
Mercoledì, Novembre 1, 2023
Gold, MP, OPSB, Elective surgery, Clubfoot, Orthopediatrics, Deformity, Patient, Parent, Dentistry, Trauma

WARSAW, Ind., Nov. 01, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the limited release of the Mitchell Ponseti Plus Bar (“MP+”) as part of their Specialty Bracing portfolio for kids with clubfoot.

Key Points: 
  • WARSAW, Ind., Nov. 01, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the limited release of the Mitchell Ponseti Plus Bar (“MP+”) as part of their Specialty Bracing portfolio for kids with clubfoot.
  • The new MP+ Bar features several innovations from their traditional Bar, which was originally launched in 2004.
  • These enhancements include:
    The company is currently developing the MP Lite boots & bar system, which will be available in markets outside the United States.
  • Joe Hauser, President of Trauma and Deformity Correction at OrthoPediatrics, added, “I am excited by this launch out of the OrthoPediatrics Specialty Bracing (“OPSB”) team in Iowa.